Annals of African Medicine
Home About AAM Editorial board Ahead of print Current Issue Archives Instructions Subscribe Contact us Search Login 
This article has been cited by
1Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
Abimbola O. Opadeyi,Annie Fourrier-Réglat,Ambrose O. Isah
BMC Pharmacology and Toxicology.2018;19(1)
[DOI]
2Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria
Theophilus A. Adegbuyi,Joseph O. Fadare,Ebisola J. Araromi,Abayomi O. Sijuade,Iyanu Bankole,Ilesanmi K. Fasuba,Rachel A. Alabi
Hospital Pharmacy.2021;56(6)751
[DOI]
3Assessment of Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting Among Healthcare Professionals working in Primary, Secondary and Tertiary Healthcare Facilities in Ekiti State, South-West Nigeria
Rabiu Yakubu,Abubakar Musa Isa,Ibrahim Jatau Abubakar,Ibrahim Oreagba,Ahmed Awaisu
Hospital Pharmacy.2020;56(6)525
[DOI]
4Causes for the underreporting of adverse drug events by health professionals: a systematic review
Fabiana Rossi Varallo,Synara de Oliveira Paim Guimarães,Samir Antonio Rodrigues Abjaude,Patricia de Carvalho Mastroianni
Revista da Escola de Enfermagem da USP.2014;48(4)739
[DOI]
5Examining characteristics, knowledge, attitude and practice of pharmacovigilance by health care professionals in Sub-Saharan Africa: A systematic review of the literature
L Mweetwa Larry,J Kenaope Thatoyaone,Mosala Bonang,Pule Kenneth,Juma Obure Gerald,Mothibe Getrude,O. Tshiamo Kabo,Tope Oluwabusola Emmanuel
African Journal of Pharmacy and Pharmacology.2021;15(8)152
[DOI]
6Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria
Abimbola O. Opadeyi,Annie Fourrier-Réglat,Ambrose O. Isah
Therapeutic Advances in Drug Safety.2019;10(8)204209861881627
[DOI]
7Level and determinants of pharmacovigilance programme awareness in Nigeria: A multilevel analysis
D. Alo Oluwafemi,O. Akinyemi Joshua,O. Akpa Matthew,B. Yusuf Oyindamola,F. Fagbamigbe Adeniyi,A. Bamgboye Elijah,B. Adebayo Samson,Kawu Issa,Agbi Perpetual,Ezire Onoriode
African Journal of Pharmacy and Pharmacology.2017;11(29)342
[DOI]
8Physicians’ Understanding and Practices of Pharmacovigilance: Qualitative Experience from a Lower Middle-Income Country
Rabia Hussain,Mohamed Azmi Hassali,Anees ur Rehman,Jaya Muneswarao,Furqan Hashmi
International Journal of Environmental Research and Public Health.2020;17(7)2209
[DOI]
9Cohort study on adverse drug reactions in adults admitted to the medical wards of a tertiary hospital in Nigeria: Prevalence, incidence, risk factors and fatality
Aduragbenro D.A. Adedapo,Waheed A. Adedeji,Ifetoluwanimi A. Adedapo,Kayode S. Adedapo
British Journal of Clinical Pharmacology.2021;87(4)1878
[DOI]
10The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals
Mariley Pérez García,Albert Figueras
Pharmacoepidemiology and Drug Safety.2011;20(12)1295
[DOI]
  Feedback 
  Subscribe